CTCX carmellrx.com Net earnings per share for the last 12 months

Public company logo of Carmell Corporation (CTCX)

The erosion of patent protection due to a shift toward the mass-market cosmetics segment creates risks, as evidenced by the rolling earnings per share over the year, where the 0.00 level records fresh values. Carmell Corporation (CTCX) bases its operations on innovative plasma materials for tissue regeneration, with development conducted in collaboration with clinics and tissue banks to accelerate patient rehabilitation.

CTCX (Carmell Therapeutics) Net earnings per share (EPS TTM) history from 02/21/2024 to 03/10/2025

Analytical breakdowns and data insights for company Carmell Therapeutics (CTCX)

- stock price and consensus target price:
Fundamental company valuation:Carmell Corp. (CTCX)
Mass-produced product of Carmell Corp

Earnings per share (EPS TTM) measures the portion of profit allocated to each security over a trailing twelve-month period. This metric reflects actual capital generation efficiency by excluding the impact of the total issuance volume. By analyzing the EPS TTM annual snapshot, an investor determines the sustainability of the asset's yield. For Carmell Corporation (CTCX), the negative trend confirms the pressure of losses and high rebranding costs. Risks associated with shifting the business model toward bio-cosmetics directly reduce the firm's liquidity.

Competitors of Carmell Corporation

Ascendis - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Madrigal Pharma|CORT (Corcept Therapeutics Incorporated) - Net earnings per share for the last 12 months|RYTM: Earnings per share for the last four quarters|AKRO (Akero Corp) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Metsera Inc|Net earnings per share (EPS TTM) MLTX|Earnings per share for the last twelve months CRNX (Crinetics Pharmaceuticals, Inc.)|Earnings per share for the last twelve months newamsterdampharma.com NAMS|Soleno Therapeutics Corp (SLNO) - Net earnings per one share for the last twelve months|FOLD - Earnings per share for the last twelve months|ETNB: Earnings per share for the last twelve months|AGIO: Net earnings per share (EPS TTM)|GPCR - Net earnings per share for the last four quarters|Earnings per share for the last twelve months MiMedx Corp|Rezolute Bio (RZLT) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months lexpharma.com (LXRX)|Net earnings per share for the last 12 months MBX Biosciences Inc MBX|Earnings per share for the last twelve months Altimmune ALT|Net earnings per share (EPS TTM) Aardvark Therapeutics AARD|Sagimet Biosciences, Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters BioAge Labs, Inc BIOA|Biomea Fusion Inc (BMEA) - Earnings per share for the last twelve months|QNCX - Net earnings per share for the last four quarters|GUTS (Fractyl Health Inc.) - Net earnings per share (EPS TTM)|VTVT: Earnings per share for the trailing year|Net earnings per share (EPS TTM) ATPC|Net earnings per share for the last four quarters Pluri Inc|Net earnings per share (EPS TTM) SYBX (Synlogic Corp)|Net earnings per share for the last four quarters lipocine.com (LPCN)|MTNB - Earnings per share for the last twelve months|Earnings per share for the trailing year SPRB (Spruce Biosciences)|GLTO (Galecto Corp) - Net earnings per share for the last 12 months|Lumos Pharma Corp - Earnings per share for the trailing year|Net earnings per share for the last 12 months ONVO|Net earnings per one share for the last twelve months Radius Recycling, Inc. RDUS